Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients.
Saved in:
| Title: | Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients. |
|---|---|
| Authors: | Colton H; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK., Barratt N; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK., Temperton N; Viral Pseudotype Unit, Medway School of Pharmacy, Universities of Kent and Greenwich, Chatham, UK., Hornsby H; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK., Angyal A; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK., Grouneva I; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK., Lindsey BB; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK., Kearns P; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK., Barnes E; Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK., Goodyear CS; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK., Richter A; Clinical Immunology Service, University of Birmingham, Birmingham, UK., Thomas D; The Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, Cambridge, UK., Cook G; National Institute for Health Research, Leeds MIC, University of Leeds, Leeds, UK., McInnes IB; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK., Willicombe M; Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, UK., Siebert S; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK., Orchard K; Department of Haematology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Selby R; Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK., Bowden S; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK., Collini PJ; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK., Pope A; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK., Kirkham A; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK., Kronsteiner B; Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK., Dunachie SJ; Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK., Miller P; British Society of Blood and Marrow Transplantation and Cellular Therapy, Guy's Hospital, London, UK., Clay J; Department of Haematology, St James's University Hospital, Leeds, UK., Hurst E; Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK., Malladi R; Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Kesavan M; Department of Oncology, Cancer and Haematology Centre, Churchill Hospital, Oxford, UK., Kinsella F; Centre for Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Sanderson R; King's College Hospital NHS Foundation Trust, London, UK., Yong KL; Department of Haematology, Cancer Institute, University College London, London, UK., Rea D; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK., Parry H; Centre for Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Lim SH; Centre for Cancer Immunology, University of Southampton, Southampton, UK., Snowden JA; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK.; Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK., de Silva TI; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK.; Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK. |
| Corporate Authors: | PITCH Consortium, OCTAVE Collaborative Group, OCTAVE‐DUO Investigators, PROSECO Investigators |
| Source: | British journal of haematology [Br J Haematol] 2024 Dec; Vol. 205 (6), pp. 2206-2218. Date of Electronic Publication: 2024 Nov 17. |
| Publication Type: | Journal Article; Multicenter Study; Comparative Study |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2141 |
|---|---|
| DOI: | 10.1111/bjh.19874 |
